The role of brain gaseous transmitters in the regulation of the circulatory system

Current Pharmaceutical Biotechnology

Volumn 12, Issue 9, 2011, Pages 1322-1333

  Ufnal, Marcin ^a   Sikora, Mariusz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Brain; Carbon monoxide; Cardiovascular system; Cytokine; Hydrogen sulphide; Nervous system; Nitric oxide

Indexed keywords

CARBON MONOXIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN SULFIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; NEUROTRANSMITTER; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRAIN REGION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; NEUROTRANSMISSION; NONHUMAN; REGULATORY MECHANISM; SYNTHESIS;

ANIMALIA;

EID: 80052234068     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111798281126     Document Type: Article

References (183)

1. Dampney, R.A.L. Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev., 1994, 74, 323-364.
2. Dampney, R.A.L.; Horiuchi, J.; Killinger, S.; Sheriff, M.J.; Tan, P.S.; McDowall, L.M. Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin. Exp. Pharmacol. Physiol., 2005, 32, 419-425.
3. Bernard, C. Influence du grand sympathique sur la sensibilité et sur la calorification. C. R. Soc. Biol. (Paris), 1851, 3, 163-170.
4. Schiff, M. Ueber den einfluss der nerven auf die gefässe der zunge. Arch. Physiol. Heilk., 1853, 12, 377-381.
5. Loewy, A.D. Viruses as transneuronal tracers for defining neural circuits. Neurosci. Biobehav. Rev., 1998, 22, 679-684.
6. Pyner, S.; Coote, J.H. Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience, 2000, 100(3), 549-556.
7. Madden, C.J.; Sved, A.F. Rostral ventrolateral medulla C1 neurons and cardiovascular regulation. Cell. Mol. Neurobiol., 2003, 23(4/5), 739-749.
8. Spyer, K.M.; Lambert, J.H.; Thomas, T. Central nervous system control of cardiovascular function: neural mechanisms and novel modulators. Clin. Exp. Pharmacol. Physiol., 1997, 24(9/10), 743-747.
9. Machado, B.H. Neurotransmission of the cardiovascular reflexes in the nucleus tractus solitarii of awake rats. Ann. N. Y. Acad. Sci., 2001, 940, 179-196.
10. Person, R.J. Somatic and vagal afferent convergence on solitary tract neurons in cat - electrophysiological characteristics. Neuroscience, 1989, 30, 283-295.
11. Feldberg, W.; Guertzenstein, P.G. Vasodepressor effects obtained by drugs acting on the ventral surface of the brain stem. J. Physiol., 1976, 258, 337-355.
12. Guertzenstein, P.G.; Silver, A. Fall in blood pressure produced from discrete regions of the ventral surface of the medulla by glycine and lesions. J. Physiol., 1974, 242, 489-503.
13. Li, Y.W.; Gieroba, Z.J.; McAllen, R.M.; Blessing, W.W. Neurons in rabbit caudal ventrolateral medulla inhibit bulbospinal barosensitive neurons in rostral medulla. Am. J. Physiol., 1991, 261, R44-R51.
14. Loewy, A.D. Forebrain nuclei involved in autonomic control. Prog. Brain Res., 1991, 87, 253-268.
15. Cottrell, G.T.; Ferguson, A.V. Sensory circumventricular organs: central roles in integrated autonomic regulation. Regul. Pept., 2004, 117, 11-23.
16. Ganong, W.F. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin. Exp. Pharmacol. Physiol., 2000, 27, 422-427.
17. Murrell, W. Nitro-glycerine as a remedy for angina pectoris. Lancet, 1879, 113(2891), 113-115.
18. Furchgott, R.F.; Zawadzki, J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 1980, 288, 373-376.
19. Ignarro, L.J.; Harbison, R.G.; Wood, K.S.; Kadowitz, P.J. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J. Pharmacol. Exp. Ther., 1986, 237(3), 893-900.
20. Ignarro, L.J.; Byrns, R.E.; Buga, G.M.; Wood, K.S. Endotheliumderived relaxing factor from pulmonary artery and vein possesses pharmacological and chemical properties that are identical to those of nitric oxide radical. Circ. Res., 1987, 61, 866-879.
21. Palmer, R.M.; Ferrige, A.G.; Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 1987, 327, 524-526.
22. Fleming, I.; Busse, R. NO: the primary EDRF. J. Mol. Cell. Cardiol., 1999, 31(1), 5-14.
23. Moncada, S.; Palmer, R.M.J.; Higgs, E.A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev., 1991, 43, 109-142.
24. Stuart-Smith, K. Demystified. nitric oxide. Mol. Pathol., 2002, 55(6), 360-366.
25. Boissel, J.P.; Schwarz, P.M.; Forstermann, U. Neuronal-type NO synthase: transcript diversity and expressional regulation. Nitric Oxide, 1998, 2(5), 337-349.
26. Reif, A.; Frohlich, L.G.; Kotsonis, P.; Frey, A.; Bommel, H.M.; Wink, D.A.; Pfleiderer, W.; Schmidt, H.H. Tetrahydrobiopterin inhibits monomerization and is consumed during catalysis in neuronal NO synthase. J. Biol. Chem., 1999, 274(35), 24921-24929.
27. Dun, N.J.; Dun, S.L.; Forstermann, U. Nitric oxide synthase immunoreactivity in rat pontine medullary neurons. Neuroscience, 1994, 59, 429-445.
28. Gai, W.P.; Blessing, W.W. Nitric oxide synthesising neurons in the central subnucleus of the nucleus tractus solitarius in humans. Neurosci. Lett., 1996, 204, 189-192.
29. Iwase, K.; Iyama, K.; Akagi, K.; Yano, S.; Fukunaga, K.; Miyamoto, E.; Mori, M.; Takiguchi, M. Precise distribution of neuronal nitric oxide synthase mRNA in the rat brain revealed by nonradioisotopic in situ hybridization. Brain Res. Mol. Brain Res., 1998, 53(1/2), 1-12.
30. Lawrence, A.J. Nitric oxide as a modulator of medullary pathways. Clin. Exp. Pharmacol. Physiol., 1997, 24, 760-763.
31. Maqbool, A.; Batten, T.F.; McWilliam, P.N. Co-localization of neurotransmitter immunoreactivities in putative nitric oxide synthesizing neurones of the cat brain stem. J. Chem. Neuroanat., 1995, 8, 191-206.
32. Zanzinger, J.; Seller, H. Species differences in the distribution of nitric oxide synthase in brain stem regions that regulate sympathetic activity. Brain Res., 1997, 764, 265-268.
33. Cabrera, C.; Bohr, D. The role of nitric oxide in the central control of blood pressure. Biochem. Biophys. Res. Commun., 1995, 206(1), 77-81.
34. Chikada, N.; Imaki, T.; Seki, T.; Harada, S.; Nakajima, K.; Yoshimoto, T.; Naruse, M.; Demura, H.; Minami, S.; Takano, K. Distribution of c-fos mRNA in the brain following intracerebroventricular injection of nitric oxide (NO)-releasing compounds: possible role of NO in central cardiovascular regulation. J. Neuroendocrinol., 2000, 12(11), 1112-1123.
35. El Karib, A.O.; Sheng, J.; Betz, A.L.; Malvin, R.L. The central effects of a nitric oxide synthase inhibitor (N omega-nitro-Larginine) on blood pressure and plasma renin. Clin. Exp. Hypertens. 1993, 15(5), 819-832.
36. Koga, N.; Takano, Y.; Honda, K.; Saito, R.; Kamiya, H. Roles of nitric oxide in the spinal cord in cardiovascular regulation in rats. Neurosci. Lett., 1999, 267(3), 173-176.
37. Moriguchi, S.; Ohzuru, N.; Koga, N.; Honda, K.; Saito, R.; Takano, Y.; Kamiya, H. Central administration of a nitric oxide synthase inhibitor causes pressor responses via the sympathetic nervous system and the renin-angiotensin system in Wistar rats. Neurosci. Lett., 1998, 245(2), 109-112.
38. Nurminen, M.L.; Ylikorkala, A.; Vapaatalo, H. Central inhibition of nitric oxide synthesis increases blood pressure and heart rate in anesthetized rats. Methods Find. Exp. Clin. Pharmacol., 1997, 19, 35-41.
39. Paczwa, P.; Budzikowski, A.S.; Szczepanska-Sadowska, E. Role of endogenous centrally released NO in cardiovascular adaptation to hypovolemia in WKY and SHR. Am. J. Physiol., 1997, 272(5 Pt 2), H2282-H2288.
40. Togashi, H.; Sakuma, I.; Yoshioka, M.; Kobayashi, T.; Yasuda, H.; Kitabatake, A.; Saito, H.; Gross, S.S.; Levi, R. A central nervous system action of nitric oxide in blood pressure regulation. Pharmacol. Exp. Ther., 1992, 262, 343-347.
41. Harada, S.; Tokunaga, S.; Momohara, M.; Masaki, H.; Tagawa, T.; Imaizumi, T.; Takeshita, A. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ. Res., 1993, 72(3), 511-516.
42. Zanzinger, J.; Czachurski, J.; Seller, H. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Am. J. Physiol., 1995, 268(4 Pt 2), R958-R962.
43. Hirooka, Y.; Polson, J.W.; Dampney, R.A. Pressor and sympathoexcitatory effects of nitric oxide in the rostral ventrolateral medulla. J. Hypertens., 1996, 14(11), 1317-1324.
44. Morimoto, S.; Sasaki, S.; Miki, S.; Kawa, T.; Nakamura, K.; Itoh, H.; Nakata, T.; Takeda, K.; Nakagawa, M.; Fushiki, S. Nitric oxide is an excitatory modulator in the rostral ventrolateral medulla in rats. Am. J. Hypertens., 2000, 13(10), 1125-1134.
45. Lage, R.C.; Campagnole-Santos, M.J.; Fontes, M.A.; Santos, R.A. Cardiovascular effects produced by nitric oxide-related drugs in the caudal ventrolateral medulla. Neuroreport, 1999, 10(4), 731-735.
46. Davisson, R.L.; Travis, M.D.; Bates, J.N.; Johnson, A.K.; Lewis, S.J. Stereoselective actions of S-nitrosocysteine in central nervous system of conscious rats. Am. J. Physiol., 1997, 272(5 Pt 2), H2361-H2368.
47. Liu, Y.; Tsuchihashi, T.; Kagiyama, S.; Matsumura, K.; Abe, I.; Fujishima, M. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats. J. Hypertens., 1998, 16(8), 1165-1173.
48. Martins-Pinge, M.C.; Baraldi-Passy, I.; Lopes, O.U. Excitatory effects of nitric oxide within the rostral ventrolateral medulla of freely moving rats. Hypertension, 1997, 30(3 Pt 2), 704-707.
49. Briski, K.P. Pharmacological manipulation of central nitric oxide/ guanylate cyclase activity alters Fos expression by rat hypothalamic vasopressinergic neurons during acute glucose deprivation. J. Chem. Neuroanat., 1999, 17(1), 13-19.
50. Chan, S.H.; Chang, K.F.; Ou, C.C.; Chan, J.Y. Nitric oxide regulates c-fos expression in nucleus tractus solitarii induced by baroreceptor activation via cGMP-dependent protein kinase and cAMP response element-binding protein phosphorylation. Mol. Pharmacol., 2004, 65(2), 319-325.
51. Sakuma, I.; Togashi, H.; Yoshioka, M.; Saito, H.; Yanagida, M.; Tamura, M.; Kobayashi, T.; Yasuda, H.; Gross, S.S.; Levi, R. N Gmethyl- L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ. Res., 1992, 70(3), 607-611.
52. Guo, Z.L.; Tjen-A-Looi, S.C.; Fu, L.W.; Longhurst, J.C. Nitric oxide in rostral ventrolateral medulla regulates cardiac-sympathetic reflexes: role of synthase isoforms. Am. J. Physiol., 2009, 297(4), H1478-H1486.
53. Lo, W.J.; Liu, H.W.; Lin, H.C.; Ger, L.P.; Tung, C.S.; Tseng, C.J. Modulatory effects of nitric oxide on baroreflex activation in the brainstem nuclei of rats. Chin. J. Physiol., 1996, 39(1), 57-62.
54. Matsumura, K.; Abe, I.; Tsuchihashi, T.; Fujishima, M. Central nitric oxide attenuates the baroreceptor reflex in conscious rabbits. Am. J. Physiol., 1998, 274(4 Pt 2), R1142-R1149.
55. Qadri, F.; Carretero, O.A.; Scicli, A.G. Centrally produced neuronal nitric oxide in the control of baroreceptor reflex sensitivity and blood pressure in normotensive and spontaneously hypertensive rats. Jpn. J. Pharmacol., 1999, 81(3), 279-285.
56. Paton, J.F.; Deuchars, J.; Ahmad, Z.; Wong, L.F.; Murphy, D.; Kasparov, S. Adenoviral vector demonstrates that angiotensin IIinduced depression of the cardiac baroreflex is mediated by endothelial nitric oxide synthase in the nucleus tractus solitarii of the rat. J. Physiol., 2001, 531(Pt 2), 445-458.
57. Haberl, R.L.; Decker, P.J.; Einhaupl, K.M. Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ. Res., 1991, 68, 1621-1627.
58. Bains, J.S.; Ferguson, A.V. Angiotensin II neurotransmitter actions in paraventricular nucleus are potentiated by a nitric oxide synthase inhibitor. Regul. Pept., 1994, 3, 53-59.
59. Chaki, S.; Inagami, T. New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis. Mol. Pharmacol., 1993, 43(4), 603-608.
60. Paton, J.F.; Lonergan, T.; Deuchars, J.; James, P.E.; Kasparov, S. Detection of angiotensin II mediated nitric oxide release within the nucleus of the solitary tract using electron-paramagnetic resonance (EPR) spectroscopy. Auton. Neurosci., 2006, 126-127+193-201.
61. Kiss, A.; Jurkovicova, D.; Jezova, D.; Krizanova, O. Changes in angiotensin AT1 receptor mRNA levels in the rat brain after immobilization stress and inhibition of central nitric oxide synthase. Endocr. Regul., 2001, 35(2), 65-70.
62. Liu, H.; Terrell, M.L.; Summy-Long, J.Y.; Kadekaro, M. Brain ANG II and prostaglandins mediate the pressor response after central blockade of nitric oxide synthase. Brain Res., 1998, 785(2), 317-328.
63. Ota, M.; Crofton, J.T.; Festavan, G.T.; Share, L. Evidence that nitric oxide can act centrally to stimulate vasopressin release. Neuroendocrinology, 1993, 57, 955-959.
64. Yamaguchi, K.; Watanabe, K.; Yamaya, K. Evaluation for roles of nitric oxide generated in the anteroventral third ventricular region in controlling vasopressin secretion and cardiovascular system of conscious rats. Eur. J. Endocrinol., 2000, 143(4), 523-533.
65. Reis, W.L.; Giusti-Paiva, A.; Ventura, R.R.; Margatho, L.O.; Gomes, D.A.; Elias, L.L.; Antunes-Rodrigues, J. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats. Exp. Physiol., 2007, 92(5), 903-911.
66. Plochocka-Zulinska, D.; Krukoff, T.L. Increased gene expression of neuronal nitric oxide synthase in brain of adult spontaneously hypertensive rats. Brain Res. Mol. Brain Res., 1997, 48(2), 291-297.
67. Waki, H.; Murphy, D.; Yao, ST.; Kasparov, S.; Paton, J.F. Endothelial NO synthase activity in nucleus tractus solitarii contributes to hypertension in spontaneously hypertensive rats. Hypertension, 2006, 48(4), 644-650.
68. Kishi, T.; Hirooka, Y.; Kimura, Y.; Sakai, K.; Ito, K.; Shimokawa, H.; Takeshita, A. Overexpression of eNOS in RVLM improves impaired baroreflex control of heart rate in SHRSP. Rostral ventrolateral medulla. Stroke-prone spontaneously hypertensive rats. Hypertension, 2003, 41(2), 255-260.
69. Paton, J.F.R.; Wang, S.; Polson, J.W.; Kasparov, S. Signalling across the blood brain barrier by angiotensin II: Novel implications for neurogenic hypertension. J. Mol. Med., 2008, 86(6), 705-710.
70. Patel, K.P.; Zhang, K.; Zucker, I.H.; Krukoff, T.L. Decreased gene expression of neuronal nitric oxide synthase in hypothalamus and brainstem of rats in heart failure. Brain Res., 1996, 734(1-2), 109-115.
71. Reddy, M.K.; Schultz, H.D.; Zheng, H.; Patel, K.P. Altered nitric oxide mechanism within the paraventricular nucleus contributes to the augmented carotid body chemoreflex in heart failure. Am. J. Physiol., 2007, 292(1), H149-H157.
72. Wang, Y.; Patel, K.P.; Cornish, K.G.; Channon, K.M.; Zucker, I.H. NNOS gene transfer to RVLM improves baroreflex function in rats with chronic heart failure. Am. J. Physiol., 2003, 285(4), H1660-H1667.
73. 2S) and sour gas effects on the eye. A historical perspective. Sci. Total. Environ., 2006, 367(1), 1-22.
74. Ramazzini, B. Diseases of Workers - De Morbis Artificum Diatriba - 1713. Wright WC (trans); C. Hafner Publishing Co. Inc: New York, 1964.
75. Beauchamp, R.O. Jr.; Bus, J.S.; Popp, J.A.; Boreiko, C.J.; Andjelkovich, D.A. A critical review of the literature on hydrogen sulfide toxicity. Crit. Rev. Toxicol., 1984, 13(1), 25-97.
76. Smith, R.P.; Gosselin, R.E. Hydrogen sulfide poisoning. J. Occup. Med., 1979, 21(2), 93-97.
77. Yalamanchili, C.; Smith, M.D. Acute hydrogen sulfide toxicity due to sewer gas exposure. Am. J. Emerg. Med., 2008, 26(4), 518-527.
78. Sluiter, E. The production of hydrogen sulphide by animal tissues. Biochem. J., 1930, 24(2), 549-563.
79. Abe, K.; Kimura, H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci., 1996, 16(3), 1066-1071.
80. 2S be the third endogenous gaseous transmitter? FASEB J., 2002, 16(13), 1792-1798.
81. Dombkowski, R.A.; Russell, M.J.; Olson, K.R. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am. J. Physiol., 2004, 286(4), R678-R685.
82. Doeller, J.E.; Isbell, T.S.; Benavides, G.; Koenitzer, J.; Patel, H.; Patel, R.P.; Lancaster, J.R. Jr.; Darley-Usmar, V.M.; Kraus, D.W. Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal. Biochem., 2005, 341(1), 40-51.
83. Erickson, P.F.; Maxwell, I.H.; Su, L.J.; Baumann, M.; Glode, L.M. Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes. Biochem. J., 1990, 269(2), 335-340.
84. Griffith, O.W. Mammalian sulfur amino acid metabolism: an overview. Methods. Enzymol., 1987, 143, 366-376.
85. Stipanuk, M.H.; Beck, P.W. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem. J., 1982, 206(2), 267-277.
86. Swaroop, M.; Bradley, K.; Ohura, T.; Tahara, T.; Roper, M.D.; Rosenberg, L.E.; Kraus, J.P. Rat cystathionine beta-synthase. Gene organization and alternative splicing. J. Biol. Chem., 1992, 267(16), 11455-11461.
87. Eto, K.; Ogasawara, M.; Umemura, K.; Nagai, Y.; Kimura, H. Hydrogen sulfide is produced in response to neuronal excitation. J. Neurosci., 2002, 22(9), 3386-3391.
88. Ishii, I.; Akahoshi, N.; Yu, X.N.; Kobayashi, Y.; Namekata, K.; Komaki, G.; Kimura, H. Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem. J., 2004, 381(Pt 1), 113-123.
89. Selhub, J. Homocysteine metabolism. Annu. Rev. Nutr., 1999, 19, 217-246.
90. Kamoun, P. Endogenous production of hydrogen sulfide in mammals. Amino Acids, 2004, 26(3), 243-254.
91. Shibuya, N.; Tanaka, M.; Yoshida, M.; Ogasawara, Y.; Togawa, T.; Ishii, K.; Kimura, H. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid. Redox. Signal., 2009, 11(4), 703-714.
92. Furne, J.; Springfield, J.; Koenig, T.; DeMaster, E.; Levitt, M.D. Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa. Biochem. Pharmacol., 2001, 62(2), 255-259.
93. Searcy, D.G.; Lee, S.H. Sulfur reduction by human erythrocytes. J. Exp. Zool., 1998, 282(3), 310-322.
94. Goodwin, L.R.; Francom, D.; Dieken, F.P.; Taylor, J.D.; Warenycia, M.W.; Reiffenstein, R.J.; Dowling, G. Determination of sulfide in brain tissue by gas dialysis/ion chromatography: postmortem studies and two case reports. J. Anal. Toxicol., 1989, 13(2), 105-109.
95. 2S) - the third gas of interest for pharmacologists. Pharmacol. Rep., 2007, 59(1), 4-24.
96. Warenycia, M.W.; Smith, K.A.; Blashko, C.S.; Kombian, S.B.; Reiffenstein, R.J. Monoamine oxidase inhibition as a sequel of hydrogen sulfide intoxication: increases in brain catecholamine and 5- hydroxytryptamine levels. Arch. Toxicol., 1989, 63(2), 131-136.
97. Li, L.; Moore, P.K. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends. Pharmacol. Sci., 2008, 29(2), 84-90.
98. Qu, K.; Lee, S.W.; Bian, J.S.; Low, C.M.; Wong, P.T. Hydrogen sulfide: neurochemistry and neurobiology. Neurochem. Int., 2008, 52(1/2), 155-165.
99. Szabo, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug. Discov., 2007, 6(11), 917-935.
100. Li, L.; Bhatia, M.; Moore, P.K. Hydrogen sulphide--a novel mediator of inflammation? Curr. Opin. Pharmacol., 2006, 6(2), 125-129.
101. Wallace, J.L. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends. Pharmacol. Sci., 2007, 28(10), 501-505.
102. Kawabata, A.; Ishiki, T.; Nagasawa, K.; Yoshida, S.; Maeda, Y.; Takahashi, T.; Sekiguchi, F.; Wada, T.; Ichida, S.; Nishikawa, H. Hydrogen sulfide as a novel nociceptive messenger. Pain, 2007, 132(1-2), 74-81.
103. Reiffenstein, R.J.; Hulbert, W.C.; Roth, S.H. Toxicology of hydrogen sulfide. Annu. Rev. Pharmacol. Toxicol., 1992, 32, 109-134.
104. Enokido, Y.; Suzuki, E.; Iwasawa, K.; Namekata, K.; Okazawa, H.; Kimura, H. Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS. FASEB J., 2005, 19(13), 1854-1856.
105. Hu, L.F.; Wong, P.T.; Moore, P.K.; Bian, J.S. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J. Neurochem., 2007, 100(4), 1121-1128.
106. 2S, a neuromodulator and smooth muscle relaxant. Nutr. Rev., 2004, 62(9), 348-353.
107. Distrutti, E.; Sediari, L.; Mencarelli, A.; Renga, B.; Orlandi, S.; Antonelli, E.; Roviezzo, F.; Morelli, A.; Cirino, G.; Wallace, J.L.; Fiorucci, S. Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J. Pharmacol. Exp. Ther., 2006, 316(1), 325-335.
108. Garcia-Bereguiain, M.A.; Samhan-Arias, A.K.; Martin-Romero, F.J.; Gutierrez-Merino, C. Hydrogen sulfide raises cytosolic calcium in neurons through activation of L-type Ca2+ channels. Antioxid. Redox. Signal., 2008, 10(1), 31-42.
109. Lee, S.W.; Hu, Y.S.; Hu, L.F.; Lu, Q.; Dawe, G.S.; Moore, P.K.; Wong, P.T.; Bian, J.S. Hydrogen sulphide regulates calcium homeostasis in microglial cells. Glia, 2006, 54(2), 116-124.
110. Lee, M.; Schwab, C.; Yu, S.; McGeer, E.; McGeer, P.L. Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol. Aging, 2009, 30(10), 1523-1534.
111. Ishigami, M.; Hiraki, K.; Umemura, K.; Ogasawara, Y.; Ishii, K.; Kimura, H. A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid. Redox. Signal., 2009, 11(2), 205-214.
112. Hosoki, R.; Matsuki, N.; Kimura, H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun., 1997, 237(3), 527-531.
113. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science, 2008, 322(5901), 587-590.
114. Zhao, W.; Zhang, J.; Lu, Y.; Wang, R.; The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J., 2001, 20(21), 6008-6016.
115. Baskar, R.; Sparatore, A.; Del Soldato, P.; Moore, P.K. Effect of Sdiclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur. J. Pharmacol., 2008, 594(1-3), 1-8.
116. Cai, W.J.; Wang, M.J.; Moore, P.K.; Jin, H.M.; Yao, T.; Zhu, Y.C. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc. Res., 2007, 76(1), 29-40.
117. 2S generated by heart in rat and its effects on cardiac function. Biochem. Biophys. Res. Commun., 2004, 313(2), 362-368.
118. 2S) protects against regional myocardial ischemiareperfusion injury--Evidence for a role of K ATP channels. Basic. Res. Cardiol., 2006, 101(1), 53-60.
119. Rossoni, G.; Sparatore, A.; Tazzari, V.; Manfredi, B.; Del Soldato, P.; Berti, F. The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart. Br. J. Pharmacol., 2008, 153(1), 100-109.
120. Yang, G.; Sun, X.; Wang, R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogenactivated protein kinases and caspase-3. FASEB J., 2004, 18(14), 1782-1784.
121. 2S on human aorta smooth muscle cells. FASEB J., 2006, 20(3), 553-555.
122. Moore, P.K.; Bhatia, M.; Moochhala, S. Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends. Pharmacol. Sci., 2003, 24(12), 609-611.
123. Olson, K.R. Vascular actions of hydrogen sulfide in nonmammalian vertebrates. Antioxid. Redox. Signal., 2005, 7(5-6), 804-812.
124. Ufnal, M.; Sikora, M.; Dudek, M. Exogenous hydrogen sulfide produces hemodynamic effects by triggering central neuroregulatory mechanisms. Acta Neurobiol. Exp. (Wars)., 2008, 68(3), 382-388.
125. Dawe, G.S.; Han, S.P.; Bian, J.S.; Moore, P.K. Hydrogen sulphide in the hypothalamus causes an ATP-sensitive K+ channeldependent decrease in blood pressure in freely moving rats. Neuroscience, 2008, 152(1), 169-177.
126. Xiao, L.; Wu, Y.M.; Zhang, H.; Liu, Y.X.; He, R.R. Hydrogen sulfide facilitates carotid sinus baroreflex in anesthetized rats. Acta Pharmacol. Sin., 2006 27(3), 294-298.
127. Dello Russo, C.; Tringali, G.; Ragazzoni, E.; Maggiano, N.; Menini, E.; Vairano, M.; Preziosi, P.; Navarra, P. Evidence that hydrogen sulphide can modulate hypothalamo-pituitary-adrenal axis function: in vitro and in vivo studies in the rat. J. Neuroendocrinol., 2000,12(3), 225-233.
128. Navarra, P.; Dello Russo, C.; Mancuso, C.; Preziosi, P.; Grossman, A.; Gaseous neuromodulators in the control of neuroendocrine stress axis. Ann. N. Y. Acad. Sci., 2000, 917, 638-646.
129. Whiteman, M.; Li, L.; Kostetski, I.; Chu, S.H.; Siau, J.L.; Bhatia, M.; Moore, P.K. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem. Biophys. Res. Commun., 2006, 343(1), 303-310.
130. Kubo, S.; Kurokawa, Y.; Doe, I.; Masuko, T.; Sekiguchi, F.; Kawabata, A. Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase. Toxicology, 2007, 241(1/2), 92-97.
131. Qingyou, Z.; Junbao, D.; Weijin, Z.; Hui, Y.; Chaoshu, T.; Chunyu, Z. Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem. Biophys. Res. Commun., 2004, 317(1), 30-37.
132. Cheung, N.S.; Peng, Z.F.; Chen, M.J.; Moore, P.K.; Whiteman, M. Hydrogen sulfide induced neuronal death occurs via glutamate receptor and is associated with calpain activation and lysosomal rupture in mouse primary cortical neurons. Neuropharmacology, 2007, 53(4), 505-514.
133. Han, Y.; Qin, J.; Chang, X.; Yang, Z.; Tang, X.; Du, J. Hydrogen sulfide may improve the hippocampal damage induced by recurrent febrile seizures in rats. Biochem. Biophys. Res. Commun., 2005, 327(2), 431-436.
134. Kimura, Y.; Dargusch, R.; Schubert, D.; Kimura, H. Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid. Redox. Signal., 2006, 8(3-4), 661-670.
135. Kombian, S.B.; Reiffenstein, R.J.; Colmers, W.F. The actions of hydrogen sulfide on dorsal raphe serotonergic neurons in vitro. J. Neurophysiol., 1993, 70(1), 81-96.
136. Kimura, H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem. Biophys. Res. Commun., 2000, 267(1), 129-133.
137. 2S in the brain? Antioxid. Redox. Signal., 2007, 9(11), 2035-2041.
138. Whiteman, M.; Armstrong, J.S.; Chu, S.H.; Jia-Ling, S.; Wong, B.S.; Cheung, N.S.; Halliwell, B.; Moore, P.K. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J. Neurochem., 2004, 90(3), 765-768.
139. Coburn, R.F.; Blakemore, W.S.; Forster, R.E. Endogenous carbon monoxide production in man. J. Clin. Invest., 1963, 42, 1172-1178.
140. Tenhunen, R.; Marver, H. S.; Schmid, R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U S A, 1968, 61(2), 748-755.
141. Verma, A.; Hirsch, D.J, Glatt, C.E.; Ronnett, G.V.; Snyder, S.H. Carbon monoxide: a putative neural messenger. Science, 1993, 259(5093): 381-384.
142. Applegate, L.A.; Luscher, P.; Tyrrell, R.M. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res., 1991, 51(3), 974-978.
143. Tyrrell, R. Redox regulation and oxidant activation of heme oxygenase- 1. Free Radic. Res., 1999, 31(4), 335-340.
144. Boehning, D.; Moon, C.; Sharma, S.; Hurt, K.J.; Hester, L.D.; Ronnett, G.V.; Shugar, D.; Snyder, S.H. Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme xygenase- 2. Neuron, 2003, 40(1), 129-137.
145. Boehning, D.; Sedaghat, L.; Sedlak, T.W.; Snyder, S.H. Heme oxygenase-2 is activated by calcium-calmodulin. J. Biol. Chem., 2004, 279(30), 30927-30930.
146. McCoubrey, W.K. Jr.; Huang, T.J.; Maines, M.D. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem., 1997, 247(2), 725-732.
147. Vreman, H.J.; Wong, R.J.; Kadotani, T.; Stevenson, D.K. Determination of carbon monoxide (CO) in rodent tissue: effect of heme administration and environmental CO exposure. Anal. Biochem., 2005, 341(2), 280-289.
148. Ewing, J.F.; Maines, M.D. Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: heme oxygenase 2 is not a heat shock protein. Proc. Natl. Acad. Sci. U S A, 1991, 88(12), 5364-5368.
149. Maines, M.D. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol., 1997, 37, 517-554.
150. Dwyer, B.E.; Nishimura, R.N.; Lu, S.Y. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res. Mol. Brain. Res., 1995, 30(1), 37-47.
151. Von Burg, R. Carbon monoxide. J. Appl. Toxicol., 1999, 19(5), 379-386.
152. Otterbein, L.E.; Choi, A.M. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol., 2000, 279(6), L1029-L1037.
153. Boehning, D.; Snyder, S.H. Circadian rhythms. Carbon monoxide and clocks. Science, 2002, 298(5602), 2339-2340.
154. Wu, L.; Wang, R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol. Rev., 2005, 57(4), 585-630.
155. Ramos, K.S.; Lin, H.; McGrath, J.J. Modulation of cyclic guanosine monophosphate levels in cultured aortic smooth muscle cells by carbon monoxide. Biochem. Pharmacol., 1989, 38(8), 1368-1370.
156. Wang, R.; Wang, Z.; Wu, L. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br. J. Pharmacol., 1997, 121(5), 927-934.
157. Johnson, R.A.; Colombari, E.; Colombari, D.S.; Lavesa, M.; Talman, W.T.; Nasjletti, A. Role of endogenous carbon monoxide in central regulation of arterial pressure. Hypertension, 1997, 30(4), 962-967.
158. Lo, W.C.; Lu, P.J.; Ho, W.Y.; Hsiao, M.; Tseng, C.J. Induction of heme oxygenase-1 is involved in carbon monoxide-mediated central cardiovascular regulation. J. Pharmacol. Exp. Ther., 2006,318(1), 8-16.
159. Lo, W.C.; Jan, C.R.; Chiang, H.T.; Tseng, C.J. Modulatory effects of carbon monoxide on baroreflex activation in nucleus tractus solitarii of rats. Hypertension, 2000, 35(6), 1253-1257.
160. Li, L.; Hsu, A.; Moore, P.K. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation--a tale of three gases! Pharmacol. Ther., 2009, 123(3), 386-400.
161. Balbay, Y.; Tikiz, H.; Baptiste, R.J.; Ayaz, S.; Sasmaz, H.; Korkmaz, S. Circulating interleukine 1- α, interleukine 6, tumor necrosis factor-α, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction. Angiology, 2001, 52, 109-114.
162. Boos, C.J.; Lip, G.Y. Is hypertension an inflammatory process? Curr. Pharm. Des., 2006, 12, 1623-1635.
163. Diwan, A.; Tran, T.; Misra, A.; Mann, D.L. Inflammatory mediators and the failing heart: a translational approach. Curr. Mol. Med., 2003, 3, 161-182.
164. Francis, J.; Zhang, Z.H.; Weiss, R.M.; Felder, R.B. Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. Am. J. Physiol., 2004, 287, H791-H797.
165. Kang, Y.M.; Zhang, Z.H.; Xue, B.; Weiss, R.M.; Felder, R.B. Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am. J. Physiol., 2008, 295(1), H227-H236.
166. Banks, W.A.; Ortiz, L.; Plotkin, S.R.; Kastin, A.J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther., 1991, 259, 988-996.
167. Fleshner, M.; Goehler, L.E.; Hermann, J.; Relton, J.K.; Maier, S.F.; Watkins, L.R. Interleukine 1-beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res. Bull., 1995, 37,605-610.
168. Kang, Y.M.; He, R.L.; Yang, L.M.; Qin, D.N.; Guggilam, A.; Elks, C.; Yan, N.; Guo Z.; Francis, J. Brain tumour necrosis factor-alpha modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure. Cardiovasc. Res., 2009, 83(4), 737-746.
169. Bataillard, A.; del Rey, A.; Klusman, I.; Arditi, G.M.; Besedovsky, H.O. Interleukin-1 stimulates aldosterone secretion: involvement of renin, ACTH, and prostaglandins. Am. J. Physiol., 1992, 263, R840-R844.
170. Fleshner, M.; Goehler, L.E.; Hermann, J.; Relton, J.K.; Maier, S.F.; Watkins, L.R. Interleukine 1-beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res. Bull., 1995, 37, 605-610.
171. Kannan, H.; Tanaka, Y.; Kunitake, T.; Ueta, Y.; Hayashida, Y.; Yamashita, H. Activation of sympathetic outflow by recombinant human interleukin-1 beta in conscious rats. Am. J. Physiol., 1996, 270, R479-R485.
172. Kimura, T.; Yamamoto, T.; Ota, K.; Shoji, M.; Inoue, M.; Sato, K.; Ohta, M.; Funyu, T.; Yoshinaga, K. Central effects of interleukin-1 on blood pressure, thermogenesis, and the release of vasopressin, ACTH, and atrial natriuretic peptide. Ann. N. Y. Acad. Sci., 1993, 689, 330-345.
173. Ufnal, M.; Sikora, M.; Szczepanska-Sadowska, E. Interleukin-1 receptor antagonist reduces the magnitude of the pressor response to acute stress. Neurosci. Lett., 2008, 448(1), 47-51.
174. Ufnal, M.; Zera, T.; Szczepanska-Sadowska, E. Blockade of angiotensin II AT1 receptors inhibits pressor action of centrally administered interleukin-1beta in Sprague Dawley rats. Neuropeptides, 2005, 39(6), 581-585.
175. Zera, T.; Ufnal, M.; Szczepanska-Sadowska, E. Central TNF-alpha elevates blood pressure and sensitizes to central pressor action of angiotensin II in the infarcted rats. J. Physiol. Pharmacol., 2008, 59(Suppl. 8), 117-121.
176. Brunetti, L.; Volpe, A.R.; Ragazzoni, E.; Preziosi, P.; Vacca, M. Interleukin-1 beta specifically stimulates nitric oxide production in the hypothalamus. Life Sci., 1996, 58(25), PL373-PL377.
177. Serou, M.J.; DeCoster, M.A.; Bazan, N.G. Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: plateletactivating factor as a preferential mediator of cyclooxygenase-2 expression. J. Neurosci. Res., 1999, 58, 593-598.
178. Monroy, M.; Kuluz, J.W.; He, D.; Dietrich, W.D.; Schleien, C.L. Role of nitric oxide in the cerebrovascular and thermoregulatory response to interleukin-1 beta. Am. J. Physiol., 2001, 280(4), H1448-H1453.
179. Ye, S.; Mozayeni, P.; Gamburd, M.; Zhong, H.; Campese, V.M. Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. Am. J. Physiol., 2000, 279, H2786-H2796.
180. Ufnal, M.; Dudek, M.; Szczepanska-Sadowska, E. Inhibition of brain nitric oxide synthesis enhances and prolongs the hypertensive effect of centrally administered interleukin-1beta in rats. Cytokine, 2006, 33(3), 166-170.
181. Guggilam, A.; Patel, K.P.; Haque, M.; Ebenezer, P.J.; Kapusta, D.R.; Francis, J. Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus. Eur. J. Heart Fail., 2008, 10(7), 625-634.
182. Sacco, G.; Evangelista, S.; Criscuoli, M.; Goso, C.; Bigioni, M.; Binaschi, M.; Manzini, S.; Maggi, C.A. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/Lnebivolol and its enantiomers in rats. Eur. J. Pharmacol., 2005, 511(2-3), 167-174.
183. Gao, L.; Wang, W.; Zucker, I.H. Simvastatin inhibits central sympathetic outflow in heart failure by a nitric-oxide synthase mechanism. J. Pharmacol. Exp. Ther., 2008, 326(1), 278-285.